As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
AMX0035 is an investigational therapy for the treatment of amyotrophic lateral sclerosis (ALS).
Dr. Raman has succeeded Victoria Richon
Biocon has reported consolidated financial results for the period ended December 31, 2021
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Effectiveness of Covaxin against the Omicron variant is currently being studied
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
Subscribe To Our Newsletter & Stay Updated
